Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin beta 8 class VIII pseudogene 7 (TUBB8P7)
- Target
- TUBB8P7
- Molecular classification
- Pseudogene
01
Overview
Tubulin beta 8 class VIII pseudogene 7 (TUBB8P7) is a genomic DNA sequence on human chromosome 16 classified as a processed pseudogene, related to the tubulin beta-8 gene (TUBB8). Unlike the functional TUBB8 gene, which encodes a key cytoskeletal protein vital in oocyte maturation and early embryogenesis, TUBB8P7 does not produce a functional protein. As a pseudogene, TUBB8P7 may participate in RNA-based regulatory mechanisms, such as acting as a competitive endogenous RNA or miRNA sponge, but has no established direct protein function or therapeutic target role. Its RNA transcript has been reported as deregulated in certain cancers (e.g., head and neck cancer), suggesting potential as a disease biomarker within gene network analyses, but not as a protein-coding or druggable target[13][12][4].
- Other names
- HSA16q24 beta-tubulin 4Q pseudogeneTUBB8 class VIII pseudogene 7
02
Biological functions
May act as a non-coding RNA regulating parental or related tubulin genes via competitive endogenous RNA (ceRNA) mechanisms or miRNA sponging (this is a general function of pseudogenes, not directly demonstrated for TUBB8P7 but is plausible given the class)[13].
03
Disease associations
Potential involvement as a biomarker or in gene regulatory networks in cancer, notably head and neck cancer, given its deregulation as a pseudogene transcript[13].No direct causal disease association established for TUBB8P7 itself.
04
Biomarkers
May be included as part of differential pseudogene transcript signatures in some cancers, notably head and neck cancer[13].
Beyond the preview
Go deeper on Tubulin beta 8 class VIII pseudogene 7 (TUBB8P7).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tubulin beta 8 class VIII pseudogene 7 (TUBB8P7).